English  |  正體中文  |  简体中文  |  Total items :0  
Visitors :  52804365    Online Users :  621
Project Commissioned by the Ministry of Education
Project Executed by National Taiwan University Library
 		 
Scope Adv. Search
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
About TAIR
About TAIR

Browse By
Institution
Author
Title
Date
Statistics Chart
Institution Facts
Trend

News
2019臺灣學術機構典藏
研討會
機構典藏系統RC7版本已
發佈

Copyright
Publisher & Journal Policy
TAIR Copyright Conference Minutes

Related Links
機構典藏計畫網站
ROAR
OpenDOAR
SHERPA
OAIster
JAIRO
Ira
DSPACE
RWWR
臺大學術典藏NTU Scholars
Taiwan Academic Institutional Repository >  Browse by Author

"yen shen lu"

Return to Browse by Author
Sorting by Title Sort by Date

Showing items 126-135 of 149  (15 Page(s) Totally)
<< < 6 7 8 9 10 11 12 13 14 15 > >>
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2020-05-25T06:51:44Z Ribociclib (RIB) + non-steroidal aromatase inhibitor (NSAI) + goserelin in premenopausal Asian women with hormone-receptor-positive (HR+), HER2-negative (HER2-) advanced breast cancer (ABC): Results from the randomized phase III MONALEESA-7 study Im S.-A;Sohn J;Tripathy D;Chow L;Lee K.S;Jung K.H;Babu G;Im Y.-H;El Saghir N;Liu M.-C;Diaz-Padilla I;Alam J;Kong O;Miller M;Yen-Shen Lu; Im S.-A; Sohn J; Tripathy D; Chow L; Lee K.S; Jung K.H; Babu G; Im Y.-H; El Saghir N; Liu M.-C; Diaz-Padilla I; Alam J; Kong O; Miller M; YEN-SHEN LU
臺大學術典藏 2020-05-25T06:51:44Z Tamoxifen (TAM) or a non-steroidal aromatase inhibitor (NSAI) with ribociclib (RIB) in premenopausal patients (pts) with hormone receptor-positive (HR+), HER2-negative (HER2-) advanced breast cancer (ABC): MONALEESA-7 subgroup analysis Bardia A;Campos-Gomez S;Hurvitz S.A;Yen-Shen Lu;Im S.-A;Franke F;Chow L;Wheatley-Price P;Melo Cruz F;Alam J;Kong O;Diaz-Padilla I;Miller M;Tripathy D.; Bardia A; Campos-Gomez S; Hurvitz S.A; YEN-SHEN LU; Im S.-A; Franke F; Chow L; Wheatley-Price P; Melo Cruz F; Alam J; Kong O; Diaz-Padilla I; Miller M; Tripathy D.
臺大學術典藏 2020-05-25T06:51:44Z Oral paclitaxel and HM30181A demonstrate clinical activity in metastatic breast cancer (MBC) patients Dai M.-S;Chao T.-Y;Chao T.-C;Chiu C.-F;Yen-Shen Lu;Shiah H.-S;Wu Y.-Y;Gerald Fetterly G;Hung N;Cutler D.L;Kwan R;Douglas Kramer D;Chan W.-K;Hung T.; Dai M.-S; Chao T.-Y; Chao T.-C; Chiu C.-F; YEN-SHEN LU; Shiah H.-S; Wu Y.-Y; Gerald Fetterly G; Hung N; Cutler D.L; Kwan R; Douglas Kramer D; Chan W.-K; Hung T.
臺大學術典藏 2020-05-25T06:51:43Z Neratinib after trastuzumab-based adjuvant therapy in patients from Asia with early stage HER2-positive breast cancer Iwata H;Masuda N;Kim S.-B;Inoue K;Rai Y;Fujita T;Chiu J;Ohtani S;Takahashi M;Miyaki T;Yen-Shen Lu;Xu B;Yap Y.S;Bustam A;Yao B;Zhang B;Bryce R;Chan A.; Iwata H; Masuda N; Kim S.-B; Inoue K; Rai Y; Fujita T; Chiu J; Ohtani S; Takahashi M; Miyaki T; YEN-SHEN LU; Xu B; Yap Y.S; Bustam A; Yao B; Zhang B; Bryce R; Chan A.
臺大學術典藏 2020-05-25T06:51:43Z Alpelisib for PIK3CA-mutated, hormone receptor-positive advanced breast cancer Andr? F;Ciruelos E;Rubovszky G;Campone M;Loibl S;Rugo H.S;Iwata H;Conte P;Mayer I.A;Kaufman B;Yamashita T;Yen-Shen Lu;Inoue K;Takahashi M;P?Pai Z;Longin A.-S;Mills D;Wilke C;Hirawat S;Juric D.; Andr? F; Ciruelos E; Rubovszky G; Campone M; Loibl S; Rugo H.S; Iwata H; Conte P; Mayer I.A; Kaufman B; Yamashita T; YEN-SHEN LU; Inoue K; Takahashi M; P?pai Z; Longin A.-S; Mills D; Wilke C; Hirawat S; Juric D.
臺大學術典藏 2020-05-25T06:51:42Z Ribociclib and Endocrine Therapy in Breast Cancer. Reply Im S.-A;Yen-Shen Lu;Tripathy D.; Im S.-A; YEN-SHEN LU; Tripathy D.
臺大學術典藏 2020-05-25T06:51:42Z Treating HR+/HER2? breast cancer in premenopausal Asian women: Asian Breast Cancer Cooperative Group 2019 Consensus and position on ovarian suppression Yeo W;Ueno T;Lin C.-H;Liu Q;Lee K.-H;Leung R;Naito Y;Park Y.H;Im S.-A;Li H;Yap Y.S;Yen-Shen Lu;The Asian Breast Cancer Cooperative Group; Yeo W; Ueno T; Lin C.-H; Liu Q; Lee K.-H; Leung R; Naito Y; Park Y.H; Im S.-A; Li H; Yap Y.S; YEN-SHEN LU; The Asian Breast Cancer Cooperative Group
臺大學術典藏 2020-05-25T06:51:42Z PI3K inhibitor provides durable response in metastatic metaplastic carcinoma of the breast: A hidden gem in the BELLE-4 study Yang M.-H;Chen I.-C;Yen-Shen Lu; Yang M.-H; Chen I.-C; YEN-SHEN LU
臺大學術典藏 2020-05-25T06:51:42Z Insights into Breast Cancer in the East vs the West: A Review Yap Y.-S;Yen-Shen Lu;Tamura K;Lee J.E;Ko E.Y;Park Y.H;Cao A.-Y;Lin C.-H;Toi M;Wu J;Lee S.-C.; Yap Y.-S; YEN-SHEN LU; Tamura K; Lee J.E; Ko E.Y; Park Y.H; Cao A.-Y; Lin C.-H; Toi M; Wu J; Lee S.-C.
臺大學術典藏 2020-05-25T06:51:42Z Contrasting Epidemiology and Clinicopathology of Female Breast Cancer in Asians vs the US Population YEN-SHEN LU; Asian Breast Cancer Cooperative Group; Cheng A.-L; Huang C.-S; Hu F.-C; Tan B; Han W; Leung R; Huang S.-M; Li H; Kwong A; Ueno T; Yeo W; Naito Y; Im S.-A; Lee K.-H; Yap Y.S; Lin C.-H; Lin C.-H;Yap Y.S;Lee K.-H;Im S.-A;Naito Y;Yeo W;Ueno T;Kwong A;Li H;Huang S.-M;Leung R;Han W;Tan B;Hu F.-C;Huang C.-S;Cheng A.-L;Yen-Shen Lu;Asian Breast Cancer Cooperative Group

Showing items 126-135 of 149  (15 Page(s) Totally)
<< < 6 7 8 9 10 11 12 13 14 15 > >>
View [10|25|50] records per page

DSpace Software Copyright © 2002-2004  MIT   &  Hewlett-Packard   /   Enhanced by   NTU Library IR team